Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 387 Breast Neoplasms 368 Colorectal Neoplasms 242 Stomach Neoplasms 222 Carcinoma, Hepatocellular 155 Lung Neoplasms 125 Neoplasms 122 Pancreatic Neoplasms 112 Prostatic Neoplasms 101 Rectal Neoplasms 98 Neoplasm Metastasis 98 Recurrence 94 Ovarian Neoplasms 92 Nasopharyngeal Carcinoma 89 Esophageal Neoplasms 84 Esophageal Squamous Cell Carcinoma 83 Lymphoma, Large B-Cell, Diffuse 80 Melanoma 78 Lymphoma 72 Small Cell Lung Carcinoma 71 Sarcoma 71 Leukemia, Myeloid, Acute 71 Uterine Cervical Neoplasms 70 Brain Neoplasms 70 Squamous Cell Carcinoma of Head and Neck 67 Multiple Myeloma 67 Head and Neck Neoplasms 67 Carcinoma, Renal Cell 65 Triple Negative Breast Neoplasms 63 Colonic Neoplasms 55

Interventions

trifluridine tipiracil drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × First-line Treatment × Clear all

NCT05077839 2021-10-25

TOBACO

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Unknown

Gastrointestinal

First-line Treatment

Data powered by HemOnc (CC BY 4.0) Colophon ⚡